Does CLONAZEPAM Cause Psychomotor hyperactivity? 138 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Psychomotor hyperactivity have been filed in association with CLONAZEPAM (Clonazepam). This represents 0.4% of all adverse event reports for CLONAZEPAM.
138
Reports of Psychomotor hyperactivity with CLONAZEPAM
0.4%
of all CLONAZEPAM reports
3
Deaths
53
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From CLONAZEPAM?
Of the 138 reports, 3 (2.2%) resulted in death, 53 (38.4%) required hospitalization, and 2 (1.4%) were considered life-threatening.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLONAZEPAM. However, 138 reports have been filed with the FAERS database.
What Other Side Effects Does CLONAZEPAM Cause?
Drug ineffective (5,088)
Toxicity to various agents (4,028)
Completed suicide (3,320)
Drug abuse (3,287)
Off label use (2,590)
Anxiety (2,376)
Somnolence (2,260)
Dyspnoea (1,987)
Depression (1,838)
Insomnia (1,836)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which CLONAZEPAM Alternatives Have Lower Psychomotor hyperactivity Risk?
CLONAZEPAM vs CLONIDINE
CLONAZEPAM vs CLOPIDOGREL
CLONAZEPAM vs CLOPIDOGREL BESILATE
CLONAZEPAM vs CLOPIDOGREL BISULFATE
CLONAZEPAM vs CLORAZEPATE